Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & Scope
    • Editorial Board
    • Contact Information
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Publication Ethics and Malpractice Statement
  • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
Antibody Responses to Trivalent Influenza Vaccine in Iranian Adults Infected with Human Immunodeficiency Virus
Mehrnaz Rasoolinejad, Sirous Jafari, Mahnaz Montazeri, Maryam Mohseni, Maryam Foroughi, Banafsheh Moradmand Badie, Minoo Saatian, Sayed Mahdi Marashi, Talat Mokhtari Azad
Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study
Mahnaz Montazeri, Marzieh Pazoki, Azar Hadadi, Melika Shafeghat, Abdolazim Veisizadeh, Mohammad Reza Khajavi, Farhad Najmeddin, Samira Kafan
Published: 2022-08-16
Effects of Remdesivir on in-Hospital and Late Outcomes of Patients With Confirmed or Clinically Suspected COVID-19: A Propensity Score-Matched Study
Azar Hadadi, Ali Ajam, Mahnaz Montazeri, Samira Kafan, Abdolazim Veisizadeh, Morteza Ghoghaei, Sina Kazemian, Arezoo Ahmadi, Fazeleh Majidi, Maryam Moghadasi, Mehdi Kashani, Faezeh Ghasemi, Marzieh Pazoki
Published: 2022-08-16
1 - 3 of 3 items

2024 CiteScore: 0.7

pISSN: 0044-6025
eISSN: 1735-9694


Editor-in-Chief:
Ahmadreza Dehpour, PharmD, PhD

 

 

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).


 

0.7
2024CiteScore
 
 
38th percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
    Publication Fee
  • For Readers
  • For Authors
  • For Librarians
Acta Medica Iranica (Monthly), pISSN: 0044-6025, eISSN: 1735-9694
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.